These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Viral antibodies in multiple sclerosis. Norrby E Prog Med Virol; 1978; 24():1-39. PubMed ID: 704893 [No Abstract] [Full Text] [Related]
4. The HLA system and multiple sclerosis. Jersild C Birth Defects Orig Artic Ser; 1978; 14(5):123-70. PubMed ID: 99191 [No Abstract] [Full Text] [Related]
5. Mediators of cellular immunity, their nature and assay. Rocklin RE J Invest Dermatol; 1976 Sep; 67(3):372-80. PubMed ID: 184210 [No Abstract] [Full Text] [Related]
6. The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens. Rocklin RE; Sheremata WA; Feldman RG; Kies MW; David JR N Engl J Med; 1971 Apr; 284(15):803-8. PubMed ID: 4323673 [No Abstract] [Full Text] [Related]
7. The HLA system and multiple sclerosis. Zanussi C; Scorza-Smeraldi R Boll Ist Sieroter Milan; 1978 Jan; 56(6):531-8. PubMed ID: 75733 [TBL] [Abstract][Full Text] [Related]
8. Mixed lymphocyte culture determinants, measles infection and multiple sclerosis. Platz P; Dupont B; Fog T; Ryder L; Thomsen M; Svejgaard A; Jersild C Proc R Soc Med; 1974 Nov; 67(11):1133-6. PubMed ID: 4140520 [No Abstract] [Full Text] [Related]
9. Multiple sclerosis: an overview. Rose AS Adv Neurol; 1981; 31():3-9. PubMed ID: 7325046 [No Abstract] [Full Text] [Related]
10. [Current data on the etiopathogenesis of multiple sclerosis]. Verdeş F Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1977; 22(3):189-99. PubMed ID: 337441 [No Abstract] [Full Text] [Related]
11. TNF as immunomodulatory agent. Bonavida B Immunol Ser; 1992; 56():315-29. PubMed ID: 1550866 [No Abstract] [Full Text] [Related]
13. [Role of autoimmunity in multiple sclerosis]. Chabas D; Liblau R Pathol Biol (Paris); 2000 Feb; 48(1):25-46. PubMed ID: 10729910 [TBL] [Abstract][Full Text] [Related]
14. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145 [TBL] [Abstract][Full Text] [Related]
15. Cellular immunity in multiple sclerosis. Rysková O; Vejbora O; Chromová L; Pekárek J; Chmelar V; Zaydlar K Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1981; 24(1):85-91. PubMed ID: 6975970 [No Abstract] [Full Text] [Related]
16. Studies on humoral immunity and HLA antigens in multiple sclerosis, optic neuritis and hereditary optic atrophy. Stendahl-Brodin L Acta Ophthalmol Suppl; 1982; 149():5-112. PubMed ID: 6282034 [No Abstract] [Full Text] [Related]
17. Multiple sclerosis immunogenetics: a) associations between HL-A antigens and high measles antibody levels. b) existence of common MLR/immune response determinants in MS patients. Cazzullo CL; Smeraldi E Boll Ist Sieroter Milan; 1974; 53(5):615-24. PubMed ID: 4282585 [No Abstract] [Full Text] [Related]
18. Influence of genetic factors on cell-mediated and humoral immunity in multiple sclerosis. Bernard CC Isr J Med Sci; 1989 Dec; 25(12):682-5. PubMed ID: 2693399 [No Abstract] [Full Text] [Related]
20. Transfer factor as a probe of the immune defect in lepromatous leprosy. Hastings RC Int J Lepr Other Mycobact Dis; 1977; 45(3):281-91. PubMed ID: 336558 [No Abstract] [Full Text] [Related] [Next] [New Search]